27 Mar 2024 Research and Development Spotlight Series – Episode 1 Blogs | Investors | R&D Spotlights Series | Therapeutics
06 Mar 2024 Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024 Therapeutics
19 Jan 2024 Appointment of Christina Coughlin, M.D., Ph.D. as Head of Research and Development Investors | Therapeutics
13 Dec 2023 ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data Investors | Therapeutics
05 Oct 2023 Avacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Investors | Therapeutics